U.S. Wound Care Market Size, Share & Industry Analysis, By Type (Advanced Wound Dressings, {Antimicrobial Dressings, Alginate Dressings, Foam Dressings, Hydrocolloid Dressings, and Others}, Traditional Wound Care Products, Negative Pressure Wound Therapy, Bioactives {Biological Skin Equivalents, Growth Factors, and Others}, and Others), By Application (Chronic Wounds {Diabetic Foot Ulcers, Pressure Ulcers, Venous Leg Ulcers, and Others} and Acute Wounds {Surgical Wounds and Burns}), By End User (Hospitals, Clinics, Homecare Settings, and Others), and Forecast, 2023-2030

The U.S. wound care market size was valued at USD 6.14 billion in 2022. The market is projected to grow from USD 6.51 billion in 2023 to USD 10.00 billion by 2030, exhibiting a CAGR of 6.3% during the forecast period.

Wound healing is a highly regulated and complex mechanism that requires various factors to work simultaneously to restore the function of injured skin. Wound care comprises traditional and advanced products, such as antimicrobial dressings, foam dressings, gauzes, AND Negative Pressure Wound Therapy (NPWT) systems, for treating chronic and acute wounds. The growing prevalence of acute and chronic wounds in the country is one of the predominant factors influencing the market’s growth in the forthcoming years.

• According to an article published in NCBI in 2021, chronic wounds are most prevalent among individuals aged above 65 years and are anticipated to affect approximately 2% of the total U.S. population.

Furthermore, the rising prevalence of chronic disorders in the country, such as diabetes and associated complications, growing initiatives by the government to raise awareness among the patient population, and shift in focus of key players to launch advanced products to treat various wounds are some of the key factors boosting the adoption of these products.

• For instance, according to a report published by the Centers for Disease Control and Prevention in 2022, an estimated 37.3 million people in the U.S. were suffering from diabetes. Moreover, it has been reported in many research articles, that about 2-5% of the U.S. population suffering from diabetes mellitus develop diabetic foot ulcers.

However, delayed diagnosis of chronic and acute wounds, along with recent product recalls, is hindering the market growth in the country.

COVID-19 IMPACT 

Delayed Wound Treatment Among Patients During COVID-19 Pandemic Slumped Market Growth

The onset of the COVID-19 pandemic slowed down the market growth in the country. Wound management was exempted from the essential procedure list during the pandemic, which negatively impacted the market. During the initial phase of the pandemic, most of the healthcare workforce was focusing on managing the crisis. Furthermore, due to the implementation of nationwide lockdowns to curb the virus transmission, many non-essential clinics were closed, and patients also postponed their visits, which highly impacted the market.

• According to a research article published in HMP Global in 2021, more than 40% of wound treatment clinics were closed for a short time in 2020. Moreover, the centers, which were hospital-based outpatient departments, witnessed a decline of 60% in their patient visits.

Additionally, various players in the country observed a significant decline in their revenue during the pandemic.

• For instance, Smith & Nephew, one of the prominent companies operating in the market, observed a revenue decline of 5.1% from its advanced wound care business segment in 2020 when compared to 2019. This was due to lesser elective surgeries and restrictions implemented on access to healthcare facilities.

However, the market is expected to reach its normal growth rate due to the growing usage of telemedicine, resumption of various surgical procedures, and lifting of lockdowns and stay-at-home orders, among others.

• For instance, Mölnlycke Health Care AB observed an increase of 10% in its sales of wound management products in 2021 as compared to the previous year.

LATEST TRENDS 

Growing Adoption of Bioactive Therapies for Late-Stage Wounds 

There is a rising shift toward the launch of bioactive therapies, such as skin substitutes, growth factors, hyaluronic-based scaffolds, and collagen-based dressings, among others, due to their various advantages. Some of these benefits include good antibacterial activity, high antioxidant activity, and fast healing, among others. These factors are increasing their adoption among end-users.

Furthermore, many key players are focusing on developing xenografts, allografts, and other dermal substitutes to treat patients suffering from chronic and acute wounds.

• For instance, in June 2021, the U.S. FDA approved StrataGraft, a bioengineered human skin graft for treating thermal burns among adult patients. The product belongs to Regenerative Medicine Advanced Therapy (RMAT) developed by Mallinckrodt in collaboration with the Biomedical Advanced Research and Development Authority, which is a part of the U.S. Department of Health and Human Services.

DRIVING FACTORS

Launch of Technologically Advanced Wound Treatment Products to Augment Market Growth

The shifting focus of key players, such as ConvaTec Group Plc, Smith & Nephew, and others, on investing in research and development, and launching advanced products in the country is anticipated to increase the adoption of these products among patients. Moreover, regulatory bodies in the country are increasing their approval of various wound management products, which is also expected to augment the market growth.

• For instance, in September 2021, Omeza, LLC received the U.S. FDA approval for its Omeza collagen matrix. The product will be used to treat pressure ulcers, diabetic ulcers, and venous ulcers, among other chronic wounds.

Furthermore, the rising initiatives of key market players to integrate digital technologies to increase awareness and improve wound management by healthcare professionals is another major factor expected to contribute to the market’s growth.

• For instance, in July 2022, Smith & Nephew launched WOUND COMPASS Clinical Support App, a digital tool that supports healthcare professionals in efficiently assessing wounds.

RESTRAINING FACTORS

Recent Product Recalls to Limit the Market Growth

Despite various initiatives by key manufacturers to develop and launch technologically advanced products to treat a wide range of wounds, some of the recent product recalls due to malfunction, expiry, and low quality are expected to hamper the adoption of these products, thereby limiting the market growth.

• For instance, in May 2022, the U.S. FDA initiated a class 3 product recall for ADVANCED MEDICAL SOLUTIONS McKesson DRESSING catalog numbers 87400, 177400, and 177200. The product’s exposure to high temperatures had impacted its effectiveness, due to which the recall was initiated.


• Additionally, in January 2022, Blaine Labs issued a voluntary product recall for RevitaDerm wound care due to bacterial contamination in the product.

SEGMENTATION

By Type Analysis

Advanced Wound Dressings to Dominate Market Owing to their Clinical Benefits

Based on type, the market is segmented into advanced wound dressings, traditional wound care products, negative pressure wound therapy, bioactives, and others. The advanced wound dressings segment is further sub-segmented into antimicrobial dressings, alginate dressings, foam dressings, hydrocolloid dressings, and others.

The advanced wound dressings segment held the largest market share in 2022 owing to increasing demand for these products as they are cost-effective. Furthermore, the wide availability of advanced wound dressings and launch & approval of new products, among others are also contributing to the segment’s growth.

• For instance, in March 2022, Zhejiang Longterm Medical Technology Co., LTD received the U.S. FDA approval for its Long term NPWT Foam Dressing kit to treat patients with acute, chronic, and traumatic wounds.

The bioactives segment is projected to exhibit the fastest growth during the forecast period. Bioactive dressings deliver active substances, such as antibiotics, peptides, and others, to the wound and promote regeneration. Additionally, they also provide a moist environment, prevent infections, and support the re-epithelization process.

Traditional products and Negative Pressure Wound Therapy (NPWT) segments are projected to record a considerable CAGR during the analysis period. Integration of advanced technologies in these devices and products, wide usage of traditional products, increase in the number of surgeries, and rising cases of acute wounds are a few factors contributing to the segment growth.

By Application Analysis

Chronic Wounds to Dominate Market Due to their Rising Prevalence Among the U.S. Population

On the basis of application, the market is segmented into chronic wounds and acute wounds. The growing prevalence of several chronic disorders, such as diabetic foot ulcers, pressure ulcers, leg ulcers, and others, is anticipated to raise the risk of chronic wounds. This factor is expected to boost the demand for these products.

• According to the Agency for Healthcare Research and Quality, an estimated 2.5 million people in the U.S. each year suffer from pressure ulcers. Moreover, these ulcers are prevalent among the old-age population.


• Furthermore, as per the United Health Foundation, about 54 million adults aged 65 years and older live in the country, which is estimated to increase to 85.7 million by 2050. Thus, the increasing pool of the geriatric population is projected to raise the risk of pressure ulcers among them, thereby accelerating the demand for chronic wound treatment products in the coming years.

The acute wounds segment is anticipated to exhibit lucrative growth during the forecast period. The rising number of surgeries in the country is likely to raise the demand for wound management products.

• According to an article published by the American Medical Association in 2021, an estimated 13 million surgical procedures were performed in the U.S. from January 2019 to January 2021.

By End User Analysis

Rising Number of Hospitals with Well-equipped Facilities Projected to Augment Market Progress

Based on end user, the market is categorized into hospitals, clinics, homecare settings, and others.

The hospitals segment is predicted to hold a major share of the market during the forecast period. The rising presence of well-established hospitals with dedicated wound management centers is one of the key factors supporting the market growth. Moreover, an increase in the admission rate of patients suffering from chronic wounds due to the availability of advanced devices and comprehensive reimbursement policies offered by hospitals is also contributing to the U.S. wound care market growth. In addition, hospitals are collaborating with key players to raise awareness and provide services to manage acute wounds, thereby promoting market progress.

• For instance, in April 2022, Healogics partnered with Vizient Hospital to provide outpatient services to manage and treat wounds efficiently.

Moreover, the homecare settings segment is expected to witness considerable growth during the forecast period. The rising demand for home healthcare services for wound treatment, launch of various products suitable for home settings, and rising geriatric population are some factors bolstering the market growth.

• For instance, in December 2021, Smith & Nephew received the FDA approval for its PICO 7 Single Use Negative Pressure Wound Therapy System to remove exudates from various wounds. Moreover, the system is suitable for hospitals and homecare settings.

KEY INDUSTRY PLAYERS

Smith & Nephew to Lead Market with Strong Product Offerings

The U.S. market is semi-consolidated, with a few well-established players in the advanced wound products segment and others in traditional products. Some players, such as 3M, Smith & Nephew, and Convatec Group PLC, among others, hold a significant U.S. wound care market share. Rising strategic activities to expand the product offerings in the country by launching new products, expanding sales channels, and inorganic strategies to strengthen market presence are contributing to the growth of these companies.

• For instance, in March 2020, Smith & Nephew launched the PICO 14 Single Use NPWT in the U.S. for patients with a higher risk of surgical site complications.

LIST OF KEY COMPANIES PROFILED:

• 3M (U.S.)


• Smith & Nephew (U.K.)


• ConvaTec Group PLC (U.K.)


• Cardinal Health (U.S.)


• Johnson & Johnson Services, Inc. (U.S.)


• Medtronic (Ireland)


• Integra Lifesciences (U.S.)


• Medline Industries, LP (U.S.)

KEY INDUSTRY DEVELOPMENTS

• January 2023 – Convatec Group PLC launched ConvaFoam in the U.S. The ConvaFoam dressing family features improved silicone technology for enhanced adhesion, seven-day wear time, improved absorbency, superabsorbent layers, and exudate monitoring. Due to all the advancements, the product can be used on a broad spectrum of wounds.


• November 2022 – InfuSystem Holdings, Inc. partnered with Sanara MedTech Inc. to develop SI Wound Care, LLC, primarily focused on delivering a complete wound management solution to improve patient outcomes at a lower cost.


• November 2021 – Convatec Group PLC extended its contract agreement for advanced wound care with Vizient, Inc. for three years. The company aimed to support patients and caregivers with high-quality products through this extension.


• June 2021 – Mölnlycke Health Care AB received the U.S. FDA approval for its Avance Solo NPWT System to remove low to moderate exudate from acute and chronic wounds.


• April 2020 – Medline Industries, LP entered into an exclusive distribution partnership with BandGrip to expand its market presence and supply wound management-associated products. 

REPORT COVERAGE

The research report provides a detailed analysis of the market and focuses on key aspects such as leading companies, competitive landscape, products, applications, and end users. Besides this, it offers insights into the latest market trends and highlights key industry developments. In addition to the factors mentioned above, the report encompasses several factors that have contributed to the growth of the market in recent years.

Report Scope & Segmentation

ATTRIBUTE	DETAILS
Study Period	2019-2030
Base Year	2022
Estimated Year	2023
Forecast Period	2023-2030
Historical Period	2019-2021
Growth Rate	CAGR of 6.3% from 2023-2030
Unit	Value (USD billion)
Segmentation	By Type, Application, and End User
By Type	Advanced Wound Dressings Antimicrobial Dressings Alginate Dressings Foam Dressings Hydrocolloid Dressings Others Traditional Wound Care Products Negative Pressure Wound Therapy Bioactives Biological Skin Equivalents Growth Factors Others Others
By Application	Chronic Wounds Diabetic Foot Ulcers Pressure Ulcers Venous Leg Ulcers Others Acute Wounds Surgical Wounds Burns
By End User	Hospitals Clinics Homecare Settings Others